Medical Collagen Market Size & Share Report 2022, 2028

Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Bovine, Porcine, and Others), Product (Gelatine, Hydrolysed Collagen, Native Collagen, and Others), and Application (Wound Care, Bone Grafts, Tissue Scaffolds, Cartilage Repair, Haemostats, Diagnostics, Vascular Grafts, and Others)

  • Report Code : TIPRE00012952
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 172
Buy Now

The medical collagen market is expected to reach US$ 957.4 million by 2028 from US$ 593.7 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is a biocompatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. It is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. The growth of the medical collagen market is attributed to the factors such as the rising applications of collagen in the medical industry, and growing FDA approvals and product launches. However, product recalls hinder the market growth.

Report Coverage

Lucrative Regions for Medical Collagen Market

Lucrative Regions for Medical Collagen Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rising Applications of Collagen in Medical Industry

Collagen is the protein found in connective tissues of the body. It is the most abundant protein found in the mammals, which makes up around 25%–35% of the whole-body protein content. As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications.

The cardiac extracellular matrix (ECM) consists of fibrillar collagen that provides a means of force transmission, preserves myocardial integrity, and supports myocyte geometry. Several studies have proved that consuming collagen supplements will help in reducing the risk of heart-related conditions.

Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Collagen has excellent ability to bind water that helps in maintaining proper water content in the skin throughout the day, which makes the skin moisturized and softened. Moreover, collagen fillers are widely used in aesthetic medicine. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing its dermatological defects.

Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes of spine, extremities, and dental. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair.

Collagen is naturally involved in the wound-healing process and the use of collagen-based wound dressings offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound, by either absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds.

These wide range of applications of collagen in the medical industry favors the growth of the market.

Product-based Insights

The medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020, and it is anticipated to register the highest CAGR in the market during the forecast period.


Medical Collagen Market, by Source – 2020 and 2028

Medical Collagen Market, by Source – 2020 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Product-based Insights

Based on product, the medical collagen market is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Application-based Insights

Based on application, the medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Medical Collagen Market: Strategic Insights

Market Size Value inUS$ 593.7 Million in 2020
Market Size Value byUS$ 957.4 Million by 2028
Growth rateCAGR of 6.2% from 2021-2028
Forecast Period2021-2028
Base Year2021
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the medical collagen market players to enlarge customer base worldwide, which, in turn, permits them to maintain their brand name globally.

Medical Collagen Market – by Source

  • Bovine
  • Porcine
  • Others

Medical Collagen Market – by Product

  • Gelatine
  • Hydrolysed Collagen
  • Native Collagen
  • Others

Medical Collagen Market – by Application

  • Wound Care
  • Bone Grafts
  • Tissue Scaffolds
  • Cartilage Repair
  • Haemostats
  • Diagnostics
  • Vascular Grafts
  • Other

Medical Collagen Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • DSM
  • Integra Lifesciences Corporation
  • Collagen Matrix Inc.
  • Encoll
  • Collagen Solutions Plc
  • Innocoll
  • Symatese
  • Gelita AG
  • Collplant Biotechnologies Ltd
  • Croda Interntional PLC.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Source , Product , and Application

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are the driving factors for the medical collagen market across the globe?

The global medical collagen market growth is mainly attributed to factors such the rising applications of collagen in medical industry and growing FDA approvals and product launches fuel the growth of the market. However, product recalls is the major factor hindering the market growth.

Who are the major players in the medical collagen market?

The medical collagen market majorly consists of the players such as DSM, Integra Lifesciences Corporation, Collagen Matrix, Inc., Encoll, Collagen Solutions Plc, Innocoll, Symatese, Gelita Ag, Collplant Biotechnologies Ltd, and Croda Interntional PLC. among others.

What is medical collagen?

Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry. The exponential increase in number of regenerative surgeries performed on patients to treat certain forms of skin cancers, burn injuries, birth defects, and congenital diseases is primarily expected to drive the demand for medical collagen.

The List of Companies - Medical Collagen Market

  1. DSM

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Collagen Market